Supplementary Data S1 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Open Access
- 15 October 2025
- other
- Published by American Association for Cancer Research (AACR)
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prostate-specific Membrane Antigen Reporting and Data System Version 2.0European Urology, 2023
- PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2023
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentEuropean Urology, 2021
- European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate BiopsyEuropean Urology, 2021
- The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic CarcinomaAmerican Journal of Surgical Pathology, 2020
- Diagnostic performance of 68Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomogramsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-upNew England Journal of Medicine, 2018
- Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image GuidanceUrology Case Reports, 2017
- 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging, 2017
- Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy ComplicationsEuropean Urology, 2017